Cargando…
CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
Most genetic alterations that drive melanoma development and resistance to targeted therapy have been uncovered. In contrast, and despite their increasingly recognized contribution, little is known about the non‐genetic mechanisms that drive these processes. Here, we performed in vivo gain‐of‐functi...
Autores principales: | Gautron, Arthur, Bachelot, Laura, Aubry, Marc, Leclerc, Delphine, Quéméner, Anaïs M, Corre, Sébastien, Rambow, Florian, Paris, Anaïs, Tardif, Nina, Leclair, Héloïse M, Marin‐Bejar, Oskar, Coulouarn, Cédric, Marine, Jean‐Christophe, Galibert, Marie‐Dominique, Gilot, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103100/ https://www.ncbi.nlm.nih.gov/pubmed/33724679 http://dx.doi.org/10.15252/emmm.202013466 |
Ejemplares similares
-
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors
por: Leclair, Héloïse M., et al.
Publicado: (2020) -
Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16
por: Quéméner, Anaïs M, et al.
Publicado: (2022) -
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
por: Corre, Sébastien, et al.
Publicado: (2018) -
The powerful world of antisense oligonucleotides: From bench to bedside
por: Quemener, Anaïs M., et al.
Publicado: (2020) -
The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma
por: Paris, Anaïs, et al.
Publicado: (2022)